Peering Into Biomarin Pharmaceutical's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Biomarin Pharmaceutical (NYSE:BMRN) has seen a 17.39% increase in its short percent of float, now at 1.89% of all regular shares. This indicates a rise in bearish sentiment, although it remains below the peer group average of 6.35%.
July 05, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biomarin Pharmaceutical's short interest has increased by 17.39%, now at 1.89% of float. This rise in short interest could indicate growing bearish sentiment among investors, although it remains below the peer group average of 6.35%.
The increase in short interest suggests that more investors are betting against the stock, which could lead to downward pressure on the stock price in the short term. However, the short interest is still below the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100